These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6896646)
1. [Comparative study of the bioavailability and the pharmacodynamic effect of five allopurinol preparations (author's transl)]. Jaeger H; Russmann D; Rasper J; Blome J Arzneimittelforschung; 1982; 32(4):438-43. PubMed ID: 6896646 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability of allopurinol oral and rectal dosage forms. Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751 [TBL] [Abstract][Full Text] [Related]
3. The bioavailability of two commercial preparations of allopurinol tablets. Marcus M; Tse FL; Kleinberg SI Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):302-5. PubMed ID: 7107081 [TBL] [Abstract][Full Text] [Related]
5. [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)]. Walter-Sack I; Gröbner W; Zöllner N Arzneimittelforschung; 1979; 29(5):839-42. PubMed ID: 582985 [TBL] [Abstract][Full Text] [Related]
6. [Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation]. Gikalov I; Radivojevich F; Schiemann O; Fenner H Arzneimittelforschung; 1986 Jun; 36(6):988-93. PubMed ID: 3741536 [TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of allopurinol-containing tablet preparations. Barthel W; Hüller G; Haustein KO Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles. Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559 [TBL] [Abstract][Full Text] [Related]
9. [The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability]. Schuster O; Haertel M; Hugemann B; Gikalov I; Schiemann O; Fenner H Arzneimittelforschung; 1985; 35(4):760-5. PubMed ID: 4015743 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers]. Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715 [TBL] [Abstract][Full Text] [Related]
11. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration. Hasan MM; Najib NM; Muti H Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684 [TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg. Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers. Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers. Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration. Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774 [TBL] [Abstract][Full Text] [Related]
17. [Relative bioavailability and influence of a quinidine retard-formulation on blood-pressure and ECG in healthy volunteers (author's transl)]. Knapp W; Lechleitner P Arzneimittelforschung; 1981; 31(9):1482-6. PubMed ID: 7197960 [TBL] [Abstract][Full Text] [Related]
18. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability of a slow-release preparation of valproic acid under steady-state conditions. Klotz U Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):24-6. PubMed ID: 6799412 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]